CSPC Pharma and AstraZeneca Forge Multibillion-Dollar Partnership to Develop Long-Acting Peptide Drugs 
OpenAI Reportedly Eyes Late-2026 IPO Amid Rising Competition and Massive Funding Needs 
Apple Faces Margin Pressure as Memory Chip Prices Surge Amid AI Boom 
Apple Earnings Beat Expectations as iPhone Sales Surge to Four-Year High 
Federal Judge Signals Possible Dismissal of xAI Lawsuit Against OpenAI 
Hyundai Motor Lets Russia Plant Buyback Option Expire Amid Ongoing Ukraine War 
US Judge Rejects $2.36B Penalty Bid Against Google in Privacy Data Case 
SpaceX Seeks FCC Approval for Massive Solar-Powered Satellite Network to Support AI Data Centers 
SpaceX Updates Starlink Privacy Policy to Allow AI Training as xAI Merger Talks and IPO Loom 
Panama Supreme Court Voids Hong Kong Firm’s Panama Canal Port Contracts Over Constitutional Violations 
Saks Global to End Saks on Amazon Partnership Amid Bankruptcy Restructuring 
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees 
Panama Supreme Court Voids CK Hutchison Port Concessions, Raising Geopolitical and Trade Concerns 
Trump Threatens Aircraft Tariffs as U.S.-Canada Jet Certification Dispute Escalates 
Apple Forecasts Strong Revenue Growth as iPhone Demand Surges in China and India 
Using the Economic Calendar to Reduce Surprise Driven Losses in Forex 
IRVINE, Calif., May 30, 2017 -- MRI Interventions, Inc. (OTCQB:MRIC), today announced that Frank Grillo, CEO, will present at the LD Micro Invitational Conference on Wednesday, June 7, 2017, at 9:00 am Pacific Time. The event will be held at the Luxe Sunset Hotel in Bel Air, California.
Management will be available to meet with investors throughout the day. Investors wishing to schedule a meeting should contact LD Micro or MRI Interventions Investor Relations at [email protected].
About MRI Interventions, Inc.
Building on the imaging power of magnetic resonance imaging (“MRI”), MRI Interventions is creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain. The ClearPoint® Neuro Navigation System, which has received 510(k) clearance and is CE marked, utilizes a hospital’s existing diagnostic or intraoperative MRI suite to enable a range of minimally invasive procedures in the brain. For more information, please visit www.mriinterventions.com.
Contact Information: Matt Kreps, Darrow Associates Investor Relations Phone: (512) 696-6401 Email: [email protected]
